πŸ‡ΊπŸ‡Έ FDA
Patent

US 11147841

Enhanced omega-3 formulations

granted A61KA61K31/232A61K31/661

Quick answer

US patent 11147841 (Enhanced omega-3 formulations) held by AKER BIOMARINE ANTARCTIC AS expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AKER BIOMARINE ANTARCTIC AS
Grant date
Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/232, A61K31/661, A61K31/685, A61K35/60